Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: PURITY LIFE HEALTH PRODUCTS A DIVISION OF SUNOPTA INC.
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02249405 | NOVO NORDISK CANADA INC | ACTIVELLE | Human | Yes | Prescription | 2 | ESTRADIOL | 1 MG |
| Marketed | 02309009 | NOVO NORDISK CANADA INC | ACTIVELLE LD | Human | Yes | Prescription | 2 | ESTRADIOL | 0.5 MG |
| Approved | 02536080 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Schedule D | 1 | CONCIZUMAB | 15 MG / 1.5 ML |
| Approved | 02536080 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Prescription | 1 | CONCIZUMAB | 15 MG / 1.5 ML |
| Approved | 02536099 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Schedule D | 1 | CONCIZUMAB | 60 MG / 1.5 ML |
| Approved | 02536099 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Prescription | 1 | CONCIZUMAB | 60 MG / 1.5 ML |
| Approved | 02536102 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Prescription | 1 | CONCIZUMAB | 150 MG / 1.5 ML |
| Approved | 02536102 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Schedule D | 1 | CONCIZUMAB | 150 MG / 1.5 ML |
| Approved | 02536110 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Prescription | 1 | CONCIZUMAB | 300 MG / 3 ML |
| Approved | 02536110 | NOVO NORDISK CANADA INC | ALHEMO | Human | Yes | Schedule D | 1 | CONCIZUMAB | 300 MG / 3 ML |
| Marketed | 02546205 | NOVO NORDISK CANADA INC | AWIQLI | Human | Yes | Schedule D | 1 | INSULIN ICODEC | 700 UNIT / ML |
| Marketed | 02546213 | NOVO NORDISK CANADA INC | AWIQLI | Human | Yes | Schedule D | 1 | INSULIN ICODEC | 1050 UNIT / 1.5 ML |
| Marketed | 02546221 | NOVO NORDISK CANADA INC | AWIQLI | Human | Yes | Schedule D | 1 | INSULIN ICODEC | 2100 UNIT / 3 ML |
| Cancelled Post Market | 02024489 | NOVO NORDISK CANADA INC | DILUTING MEDIUM FOR INSULIN ZINC INJECTABLE SUSPENSION | Human | No | Ethical | 1 | WATER | 1 ML / 1 ML |
| Cancelled Post Market | 02024470 | NOVO NORDISK CANADA INC | DILUTING MEDIUM FOR ISOPHANE INSULIN INJECTION | Human | No | Ethical | 1 | WATER | 1 ML / 1 ML |
| Cancelled Post Market | 02025272 | NOVO NORDISK CANADA INC | DILUTING MEDIUM FOR SOLUBLE INSULIN INJECTION | Human | No | Ethical | 1 | WATER | 1 ML / 1 ML |
| Marketed | 02490064 | NOVO NORDISK CANADA INC | ESPEROCT | Human | Yes | Schedule D | 1 | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED | 500 UNIT / VIAL |
| Marketed | 02490072 | NOVO NORDISK CANADA INC | ESPEROCT | Human | Yes | Schedule D | 1 | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED | 1000 UNIT / VIAL |
| Approved | 02490080 | NOVO NORDISK CANADA INC | ESPEROCT | Human | Yes | Schedule D | 1 | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED | 1500 UNIT / VIAL |
| Marketed | 02490099 | NOVO NORDISK CANADA INC | ESPEROCT | Human | Yes | Schedule D | 1 | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED | 2000 UNIT / VIAL |
| Marketed | 02490102 | NOVO NORDISK CANADA INC | ESPEROCT | Human | Yes | Schedule D | 1 | ANTIHEMOPHILIC FACTOR VIII (RECOMBINANT, B-DOMAIN TRUNCATED), PEGYLATED | 3000 UNIT / VIAL |
| Marketed | 02460408 | NOVO NORDISK CANADA INC | FIASP | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Marketed | 02460416 | NOVO NORDISK CANADA INC | FIASP | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Marketed | 02460424 | NOVO NORDISK CANADA INC | FIASP | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Cancelled Post Market | 02333619 | NOVO NORDISK CANADA INC | GLUCAGEN | Human | Yes | Schedule D | 1 | GLUCAGON (RECOMBINANT DNA ORIGIN) (GLUCAGON HYDROCHLORIDE) | 1 MG / VIAL |
| Marketed | 02333627 | NOVO NORDISK CANADA INC | GLUCAGEN HYPOKIT | Human | Yes | Schedule D | 1 | GLUCAGON (RECOMBINANT DNA ORIGIN) (GLUCAGON HYDROCHLORIDE) | 1 MG / VIAL |
| Cancelled Post Market | 02239924 | NOVO NORDISK CANADA INC | GLUCONORM 0.5MG | Human | Yes | Prescription | 1 | REPAGLINIDE | 0.5 MG |
| Cancelled Post Market | 02239925 | NOVO NORDISK CANADA INC | GLUCONORM 1.0MG | Human | Yes | Prescription | 1 | REPAGLINIDE | 1.0 MG |
| Cancelled Post Market | 02239926 | NOVO NORDISK CANADA INC | GLUCONORM 2.0MG | Human | Yes | Prescription | 1 | REPAGLINIDE | 2.0 MG |
| Cancelled Post Market | 02412829 | NOVO NORDISK CANADA INC | LEVEMIR FLEXTOUCH | Human | Yes | Schedule D | 1 | INSULIN DETEMIR | 100 UNIT / ML |
| Marketed | 02271842 | NOVO NORDISK CANADA INC | LEVEMIR PENFILL | Human | Yes | Schedule D | 1 | INSULIN DETEMIR | 100 UNIT / ML |
| Cancelled Post Market | 02056682 | NOVO NORDISK CANADA INC | LOGIPARIN LIQ SC 10000 FXAIU/ML | Human | No | Prescription | 1 | TINZAPARIN SODIUM | 10000 UNIT / ML |
| Cancelled Post Market | 02239659 | NOVO NORDISK CANADA INC | NIASTASE | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 1.2 MG / VIAL |
| Cancelled Post Market | 02239660 | NOVO NORDISK CANADA INC | NIASTASE | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 2.4 MG / VIAL |
| Cancelled Post Market | 02239661 | NOVO NORDISK CANADA INC | NIASTASE | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 4.8 MG / VIAL |
| Approved | 02347113 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 1 MG / VIAL |
| Approved | 02347121 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 2 MG / VIAL |
| Approved | 02347148 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 5 MG / VIAL |
| Approved | 02365669 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 8 MG / VIAL |
| Marketed | 02417103 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 1 MG / VIAL |
| Marketed | 02417111 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 2 MG / VIAL |
| Marketed | 02417138 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | Yes | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 5 MG / VIAL |
| Approved | 02417146 | NOVO NORDISK CANADA INC | NIASTASE RT | Human | No | Schedule D | 1 | EPTACOG ALFA (ACTIVATED) | 8 MG / VIAL |
| Marketed | 02529181 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Schedule D | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Marketed | 02529181 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Prescription | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Marketed | 02529203 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Prescription | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Marketed | 02529203 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Schedule D | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Marketed | 02529211 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Schedule D | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Marketed | 02529211 | NOVO NORDISK CANADA INC | NORDITROPIN FLEXPRO | Human | Yes | Prescription | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Cancelled Post Market | 02334852 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Prescription | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Cancelled Post Market | 02334852 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Schedule D | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Cancelled Post Market | 02334860 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Prescription | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Cancelled Post Market | 02334860 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Schedule D | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Cancelled Post Market | 02334879 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Schedule D | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Cancelled Post Market | 02334879 | NOVO NORDISK CANADA INC | NORDITROPIN NORDIFLEX | Human | Yes | Prescription | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Cancelled Post Market | 02334925 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Schedule D | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Cancelled Post Market | 02334925 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Prescription | 1 | SOMATROPIN | 5 MG / 1.5 ML |
| Cancelled Post Market | 02334941 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Schedule D | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Cancelled Post Market | 02334941 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Prescription | 1 | SOMATROPIN | 10 MG / 1.5 ML |
| Cancelled Post Market | 02334968 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Prescription | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Cancelled Post Market | 02334968 | NOVO NORDISK CANADA INC | NORDITROPIN SIMPLEXX | Human | Yes | Schedule D | 1 | SOMATROPIN | 15 MG / 1.5 ML |
| Marketed | 02024217 | NOVO NORDISK CANADA INC | NOVOLIN GE 30/70 | Human | Yes | Schedule D | 2 | INSULIN INJECTION HUMAN BIOSYNTHETIC | 30 UNIT / ML |
| Marketed | 02025248 | NOVO NORDISK CANADA INC | NOVOLIN GE 30/70 PENFILL | Human | Yes | Schedule D | 2 | INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 70 UNIT / ML |
| Cancelled Post Market | 02024314 | NOVO NORDISK CANADA INC | NOVOLIN GE 40/60 PENFILL | Human | Yes | Schedule D | 2 | INSULIN INJECTION HUMAN BIOSYNTHETIC | 40 UNIT / ML |
| Cancelled Post Market | 02024322 | NOVO NORDISK CANADA INC | NOVOLIN GE 50/50 PENFILL | Human | Yes | Schedule D | 2 | INSULIN INJECTION HUMAN BIOSYNTHETIC | 50 UNIT / ML |
| Marketed | 02024225 | NOVO NORDISK CANADA INC | NOVOLIN GE NPH | Human | Yes | Schedule D | 1 | INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 100 UNIT / ML |
| Marketed | 02024268 | NOVO NORDISK CANADA INC | NOVOLIN GE NPH PENFILL | Human | Yes | Schedule D | 1 | INSULIN ISOPHANE HUMAN BIOSYNTHETIC | 100 UNIT / ML |
| Marketed | 02024233 | NOVO NORDISK CANADA INC | NOVOLIN GE TORONTO | Human | Yes | Schedule D | 1 | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML |
| Marketed | 02024284 | NOVO NORDISK CANADA INC | NOVOLIN GE TORONTO PENFILL | Human | Yes | Schedule D | 1 | INSULIN INJECTION HUMAN BIOSYNTHETIC | 100 UNIT / ML |
| Marketed | 02265435 | NOVO NORDISK CANADA INC | NOVOMIX 30 | Human | Yes | Schedule D | 2 | INSULIN ASPART | 30 UNIT / ML |
| Cancelled Pre Market | 02265443 | NOVO NORDISK CANADA INC | NOVOMIX 30 (FLEXPEN) | Human | Yes | Schedule D | 2 | INSULIN ASPART | 30 % |
| Marketed | 02244353 | NOVO NORDISK CANADA INC | NOVORAPID | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Marketed | 02245397 | NOVO NORDISK CANADA INC | NOVORAPID | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Cancelled Post Market | 02377209 | NOVO NORDISK CANADA INC | NOVORAPID | Human | Yes | Schedule D | 1 | INSULIN ASPART | 100 UNIT / ML |
| Marketed | 02471469 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1.34 MG / ML |
| Marketed | 02471469 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1.34 MG / ML |
| Marketed | 02471477 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1.34 MG / ML |
| Marketed | 02471477 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1.34 MG / ML |
| Approved | 02523930 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 2.68 MG / ML |
| Approved | 02523930 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 2.68 MG / ML |
| Marketed | 02540258 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 0.68 MG / ML |
| Marketed | 02540258 | NOVO NORDISK CANADA INC | OZEMPIC | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 0.68 MG / ML |
| Marketed | 02470187 | NOVO NORDISK CANADA INC | REBINYN | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED | 500 UNIT / VIAL |
| Marketed | 02470268 | NOVO NORDISK CANADA INC | REBINYN | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED | 1000 UNIT / VIAL |
| Marketed | 02470276 | NOVO NORDISK CANADA INC | REBINYN | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED | 2000 UNIT / VIAL |
| Marketed | 02532964 | NOVO NORDISK CANADA INC | REBINYN | Human | Yes | Schedule D | 1 | COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED | 3000 UNIT / VIAL |
| Marketed | 02497581 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 3 MG |
| Marketed | 02497581 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 3 MG |
| Marketed | 02497603 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 7 MG |
| Marketed | 02497603 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 7 MG |
| Marketed | 02497611 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 14 MG |
| Marketed | 02497611 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 14 MG |
| Approved | 02551012 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1.5 MG |
| Approved | 02551012 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1.5 MG |
| Approved | 02551020 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 4 MG |
| Approved | 02551020 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 4 MG |
| Approved | 02551039 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 9 MG |
| Approved | 02551039 | NOVO NORDISK CANADA INC | RYBELSUS | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 9 MG |
| Marketed | 02437899 | NOVO NORDISK CANADA INC | SAXENDA | Human | Yes | Prescription | 1 | LIRAGLUTIDE | 6 MG / ML |
| Marketed | 02437899 | NOVO NORDISK CANADA INC | SAXENDA | Human | Yes | Schedule D | 1 | LIRAGLUTIDE | 6 MG / ML |
| Marketed | 02539934 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Schedule D | 1 | SOMAPACITAN | 5 MG / 1.5 ML |
| Marketed | 02539934 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Prescription | 1 | SOMAPACITAN | 5 MG / 1.5 ML |
| Marketed | 02539942 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Prescription | 1 | SOMAPACITAN | 10 MG / 1.5 ML |
| Marketed | 02539942 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Schedule D | 1 | SOMAPACITAN | 10 MG / 1.5 ML |
| Marketed | 02539950 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Schedule D | 1 | SOMAPACITAN | 15 MG / 1.5 ML |
| Marketed | 02539950 | NOVO NORDISK CANADA INC | SOGROYA | Human | Yes | Prescription | 1 | SOMAPACITAN | 15 MG / 1.5 ML |
| Marketed | 02467860 | NOVO NORDISK CANADA INC | TRESIBA | Human | Yes | Schedule D | 1 | INSULIN DEGLUDEC | 100 UNIT / ML |
| Marketed | 02467879 | NOVO NORDISK CANADA INC | TRESIBA | Human | Yes | Schedule D | 1 | INSULIN DEGLUDEC | 100 UNIT / ML |
| Marketed | 02467887 | NOVO NORDISK CANADA INC | TRESIBA | Human | Yes | Schedule D | 1 | INSULIN DEGLUDEC | 200 UNIT / ML |
| Marketed | 02389975 | NOVO NORDISK CANADA INC | TRETTEN | Human | Yes | Schedule D | 1 | CATRIDECACOG | 2500 UNIT / VIAL |
| Cancelled Post Market | 02241332 | NOVO NORDISK CANADA INC | VAGIFEM | Human | Yes | Prescription | 1 | ESTRADIOL | 25 MCG |
| Marketed | 02325462 | NOVO NORDISK CANADA INC | VAGIFEM 10 | Human | Yes | Prescription | 1 | ESTRADIOL (ESTRADIOL HEMIHYDRATE) | 10 MCG |
| Marketed | 02351064 | NOVO NORDISK CANADA INC | VICTOZA | Human | Yes | Schedule D | 1 | LIRAGLUTIDE | 6 MG / ML |
| Marketed | 02351064 | NOVO NORDISK CANADA INC | VICTOZA | Human | Yes | Prescription | 1 | LIRAGLUTIDE | 6 MG / ML |
| Approved | 02522551 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 0.25 MG / 0.5 ML |
| Approved | 02522551 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 0.25 MG / 0.5 ML |
| Approved | 02522578 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 0.5 MG / 0.5 ML |
| Approved | 02522578 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 0.5 MG / 0.5 ML |
| Approved | 02522586 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1 MG / 0.5 ML |
| Approved | 02522586 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1 MG / 0.5 ML |
| Approved | 02522594 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1.7 MG / 0.75 ML |
| Approved | 02522594 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1.7 MG / 0.75 ML |
| Approved | 02522608 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 2.4 MG / 0.75 ML |
| Approved | 02522608 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 2.4 MG / 0.75 ML |
| Marketed | 02528509 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 1 MG / 1.5 ML |
| Marketed | 02528509 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 1 MG / 1.5 ML |
| Marketed | 02528517 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 2 MG / 1.5 ML |
| Marketed | 02528517 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 2 MG / 1.5 ML |
| Marketed | 02528525 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 4 MG / 3 ML |
| Marketed | 02528525 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 4 MG / 3 ML |
| Marketed | 02528533 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 6.8 MG / 3 ML |
| Marketed | 02528533 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 6.8 MG / 3 ML |
| Marketed | 02528541 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 9.6 MG / 3 ML |
| Marketed | 02528541 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 9.6 MG / 3 ML |
| Approved | 02552698 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Prescription | 1 | SEMAGLUTIDE | 2 MG / 3 ML |
| Approved | 02552698 | NOVO NORDISK CANADA INC | WEGOVY | Human | Yes | Schedule D | 1 | SEMAGLUTIDE | 2 MG / 3 ML |
| Marketed | 02474875 | NOVO NORDISK CANADA INC | XULTOPHY | Human | Yes | Prescription | 2 | INSULIN DEGLUDEC | 100 UNIT / ML |
| Marketed | 02474875 | NOVO NORDISK CANADA INC | XULTOPHY | Human | Yes | Schedule D | 2 | INSULIN DEGLUDEC | 100 UNIT / ML |
| Marketed | 02435187 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 250 UNIT / VIAL |
| Marketed | 02435195 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 500 UNIT / VIAL |
| Marketed | 02435209 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 1000 UNIT / VIAL |
| Marketed | 02435217 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 1500 UNIT / VIAL |
| Marketed | 02435225 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 2000 UNIT / VIAL |
| Marketed | 02435233 | NOVO NORDISK CANADA INC | ZONOVATE | Human | Yes | Schedule D | 1 | TUROCTOCOG ALFA | 3000 UNIT / VIAL |
Application information
Related information
Contact us
Version 4.0.3